These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3348466)

  • 61. A longitudinal study of children of alcoholics: predicting young adult substance use disorders, anxiety, and depression.
    Chassin L; Pitts SC; DeLucia C; Todd M
    J Abnorm Psychol; 1999 Feb; 108(1):106-19. PubMed ID: 10066997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is access to alcohol associated with alcohol/substance abuse among people diagnosed with anxiety/mood disorder?
    Pearson AL; Bowie C; Thornton LE
    Public Health; 2014 Nov; 128(11):968-76. PubMed ID: 25443109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nicotine dependence, major depression, and anxiety in young adults.
    Breslau N; Kilbey M; Andreski P
    Arch Gen Psychiatry; 1991 Dec; 48(12):1069-74. PubMed ID: 1845224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Organic anxiety disorder with symptoms of akathisia in a patient treated with the immunosuppressant FK506.
    Bernstein L; Daviss SR
    Gen Hosp Psychiatry; 1992 May; 14(3):210-1. PubMed ID: 1376291
    [No Abstract]   [Full Text] [Related]  

  • 65. What do we know about affective disorders?
    Favazza A
    Am J Psychiatry; 1986 Oct; 143(10):1328. PubMed ID: 3766813
    [No Abstract]   [Full Text] [Related]  

  • 66. DSM-III-R criteria for cocaine disorders.
    Satel SL; Seibyl JP
    Am J Psychiatry; 1991 Aug; 148(8):1088. PubMed ID: 1853964
    [No Abstract]   [Full Text] [Related]  

  • 67. A framework for refining the diagnostic categorization of substance abusers.
    Alterman AI; McLellan AT
    Addict Behav; 1981; 6(1):23-7. PubMed ID: 7257912
    [No Abstract]   [Full Text] [Related]  

  • 68. Severity-based classification of mood and anxiety symptoms.
    Wahl W
    J Am Board Fam Pract; 2000; 13(2):159-60. PubMed ID: 10764204
    [No Abstract]   [Full Text] [Related]  

  • 69. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I).
    Skre I; Onstad S; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1991 Aug; 84(2):167-73. PubMed ID: 1950612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Chou KL; Mackenzie CS; Liang K; Sareen J
    J Clin Psychiatry; 2011 Feb; 72(2):144-55. PubMed ID: 21382305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential diagnosis in MH settings: heed signs of substance abuse.
    Sauerland RM
    Behav Healthc Tomorrow; 2003 Oct; 12(5):36-8. PubMed ID: 14564969
    [No Abstract]   [Full Text] [Related]  

  • 72. Organic affective illness associated with lead intoxication.
    Schottenfeld RS; Cullen MR
    Am J Psychiatry; 1984 Nov; 141(11):1423-6. PubMed ID: 6496787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The organic mental disorders subsection of DSM-III-R.
    Bedi A
    Am J Psychiatry; 1988 Apr; 145(4):534-5. PubMed ID: 3348466
    [No Abstract]   [Full Text] [Related]  

  • 74. DSM-5 proposals for mood disorders: a cost-benefit analysis.
    First MB
    Curr Opin Psychiatry; 2011 Jan; 24(1):1-9. PubMed ID: 21042219
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.